News


$6 million CPRIT award to bring veteran cancer researcher

March 2, 2021

UT Health San Antonio and its Mays Cancer Center will receive a $6 million award from the Cancer Prevention and Research Institute of Texas to recruit Alexander Mazin, PhD, a senior, highly accomplished biochemist and cancer biologist currently at Drexel University College of Medicine.




Journal article reviews century of data showing COVID-19 likely to impact the brain

January 19, 2021

An article published in Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association cites decades of published scientific evidence to make a compelling case for SARS-CoV-2’s expected long-term effects on the brain and nervous system.




Novavax COVID-19 vaccine trial opens at UT Health San Antonio, University Health

January 7, 2021

San Antonians will have the opportunity to participate in the fifth international COVID-19 vaccine clinical trial beginning in January. Locally, 500 participants are being sought.




Drinking alcohol blocks a chemical that promotes attention

December 22, 2020

In a new paper, researchers from UT Health San Antonio report brain chemistry that may contribute to why drinkers have difficulty paying attention while under the influence.




UT Health San Antonio, UT Southwestern get $1 million to establish brain bank program

December 3, 2020

Through this initiative, families throughout Texas will have access to vital brain donation services and researchers will be able to diagnose numerous neurodegenerative disorders using brain autopsy tissue.




Can a statin maintain the health of adults 75 and older?

November 20, 2020

PREVENTABLE clinical trial at UT Health San Antonio recruiting 450 volunteers.



Department of Emergency Medicine research news

November 6, 2020

The Department of Emergency Medicine in the Joe R. and Teresa Lozano Long School of Medicine has released the latest issue of its research newsletter. Check out the November 2020 issue



Viral ‘molecular scissor’ is next COVID-19 drug target

October 22, 2020

Scientists laid out the framework for a new COVID-19 drug design that blocks the virus from replicating and disabling human proteins crucial to the immune response.




Researchers solve 100-year-old mystery of what activates magnesium ions in the cell

October 15, 2020

The discovery is expected to be a springboard for future development of novel drugs to treat cardiovascular disease, metabolic disorders such as diabetes and other diseases.




Dr. Mingjiang Xu receives UT System award to support cancer epigenetics research

October 9, 2020

Mingjiang Xu, MD, PhD, professor of molecular medicine, was awarded a $1 million UT System Faculty STARs award to enhance cancer epigenetics research and support the discovery of targeted therapeutics for blood cancers.